For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
WHO accused of 'denying science' over airborne spread of SARS-CoV-2
+News
WHO accused of 'denying science' over airborne spread of SARS-CoV-2
Tuesday 7 July 2020, 12:37 PM

Researchers say there is growing evidence that the virus is released in droplets during breathing, talking and coughing which are small enough to remain suspended in the air
A group of Australian and international scientists has accused the WHO of downplaying the significance of airborne transmission of COVID-19 and urged
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.